AR
ASPN icon

Advisory Research’s Aspen Aerogels ASPN Stock Holding History

Advisory Research’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-87,936
Closed -$1.39M – 172
2023
Q4 		$1.39M Buy
87,936
+62,112
+241% +$641K 0.21% 123
2023
Q3 		$222K Buy
+25,824
New +$183K 0.03% 407
2023
Q1 		– Sell
-23,500
Closed -$277K – 359
2022
Q4 		$277K Buy
23,500
+3,303
+16% +$37.7K 0.03% 309
2022
Q3 		$186K Buy
+20,197
New +$245K 0.02% 316
2022
Q2 		– Sell
-21,523
Closed -$742K – 374
2022
Q1 		$742K Sell
21,523
-41,759
-66% -$1.36M 0.06% 214
2021
Q4 		$3.15M Buy
63,282
+15,643
+33% +$824K 0.25% 73
2021
Q3 		$2.19M Buy
+47,639
New +$1.89M 0.14% 122

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $1.04B AUM 36.93% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ECA
Encompass Capital Advisors New York $2.81B AUM 198.36% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Advisory Research's ASPN Position: Q1 2024 in Review

Advisory Research sold out of Aspen Aerogels (ASPN) in Q1 2024, closing a stake of 87,936 shares — an estimated $1.39M sold.

Advisory Research first reported a position in ASPN in Q3 2021 and held it in 7 quarters. The position peaked at $3.15M in Q4 2021. 167 funds tracked by Wall St. Rank hold ASPN as of Q1 2024.

  • Advisory Research reported no remaining Aspen Aerogels position as of Q1 2024 after selling out during the quarter.
  • Advisory Research sold 87,936 Aspen Aerogels shares in Q1 2024, an estimated $1.39M.
  • Advisory Research first reported a position in Aspen Aerogels in Q3 2021 and held it in 7 quarters.
  • Advisory Research's Aspen Aerogels position peaked at $3.15M in Q4 2021.
  • 167 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2024.

Based on Advisory Research's 13F filing for Q1 2024, filed 14 May 2024.